Non-Alcoholic Fatty Liver Disease and Prediabetes

被引:0
|
作者
Mansour-Ghanaei, Fariborz [1 ]
Jafarinejad, Alireza [1 ]
Roshan, Zahra Atrkar [1 ]
Khosravi, Hadi [1 ]
Hassankhani, Amir [2 ]
Maafi, Alireza Amir [2 ]
机构
[1] Guilan Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr, Rasht, Iran
[2] Guilan Univ Med Sci, Student Res Ctr, Rasht, Iran
来源
JOURNAL OF PIONEERING MEDICAL SCIENCES | 2016年 / 6卷 / 01期
关键词
Non-alcoholic Fatty Liver Disease; Prediabetes; Ultrasonography;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. The simultaneous occurrence of NAFLD and type 2 diabetes is common, however, few studies on the prevalence of NAFLD in prediabetic patients have been performed. Therefore, the aim of this study was to determine the prevalence of NAFLD by sonography in prediabetic patients and to compare the prevalence of NAFLD between prediabetic patients and normal population. METHODS: In this cross-sectional study, 191 consecutive prediabetic patients who were referred to the internal medicine clinic in the Razi Referral Hospital of Rasht, Iran, were compared with 191 healthy controls. Diagnosis of prediabetes was based on abnormal oral glucose tolerance test or fasting plasma glucose. Both groups underwent ultrasonography for the assessment of NAFLD and data was analyzed by Student's t test and Chi-square test. RESULTS: Patient population was between 20 and 70 years old and the mean age of participants was 41.04 +/- 12.66 years. Prediabetic group had 71(37.1%) males while healthy group had 84(43.9%) males. Of the 382 subjects, 142 (37.2%) had evidence of NAFLD on ultrasound examination of which 93(65.4%) were prediaibetics (P=0.001). CONCLUSION: We show that the prevalence of NAFLD in prediabetic patients is higher than healthy individual.
引用
收藏
页码:6 / 9
页数:4
相关论文
共 50 条
  • [41] Non-alcoholic fatty liver disease in pregnancy
    Benson, Charlotte S.
    Cobbold, Jeremy F.
    Frise, Charlotte J.
    OBSTETRIC MEDICINE, 2023, 16 (02) : 116 - 119
  • [42] Epidemiology of Non-Alcoholic Fatty Liver Disease
    Bellentani, Stefano
    Scaglioni, Federica
    Marino, Mariano
    Bedogni, Giorgio
    DIGESTIVE DISEASES, 2010, 28 (01) : 155 - 161
  • [43] Managing non-alcoholic fatty liver disease
    Ngu, Jing Hieng
    Goh, George Boon Bee
    Poh, Zhongxian
    Soetikno, Roy
    SINGAPORE MEDICAL JOURNAL, 2016, 57 (07) : 368 - 370
  • [44] Platelets in Non-alcoholic Fatty Liver Disease
    Dalbeni, Andrea
    Castelli, Marco
    Zoncape, Mirko
    Minuz, Pietro
    Sacerdoti, David
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [45] Management of non-alcoholic fatty liver disease
    Lanuza, Fabian
    Sapunar, Jorge
    Hofmann, Edmundo
    REVISTA MEDICA DE CHILE, 2018, 146 (08) : 894 - 901
  • [46] Non-Alcoholic Fatty Liver Disease and Vascular Disease
    Forlano, Roberta
    Mullish, Benjamin H.
    Nathwani, Rooshi
    Dhar, Ameet
    Thursz, Mark R.
    Manousou, Pinelopi
    CURRENT VASCULAR PHARMACOLOGY, 2021, 19 (03) : 269 - 279
  • [47] Glycosyltransferases and non-alcoholic fatty liver disease
    Yu-Tao Zhan
    Hai-Ying Su
    Wei An
    World Journal of Gastroenterology, 2016, (08) : 2483 - 2493
  • [48] Non-alcoholic fatty liver disease in 2015
    Monjur Ahmed
    World Journal of Hepatology, 2015, (11) : 1450 - 1459
  • [49] miRNAs in non-alcoholic fatty liver disease
    He, Zhen
    Hu, Cheng
    Jia, Weiping
    FRONTIERS OF MEDICINE, 2016, 10 (04) : 389 - 396
  • [50] Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
    Cuthbertson, Daniel J.
    Koskinen, Juha
    Brown, Emily
    Magnussen, Costan G.
    Hutri-Kahonen, Nina
    Sabin, Matthew
    Tossavainen, Paivi
    Jokinen, Eero
    Laitinen, Tomi
    Viikari, Jorma
    Raitakari, Olli T.
    Juonala, Markus
    ANNALS OF MEDICINE, 2021, 53 (01) : 1256 - 1264